Genzyme acquires Lisfarma

GENZ acquired Lisfarma (Sao Paolo, Brazil) for $1.1 million in cash, in a move to accelerate the Brazilian launch of GENZ's Renagel non-absorbed phosphate binder to treat patients on dialysis with end...